The choreography of neuroinflammation in Huntington's disease

Crotti, Andrea, Glass, Christopher K.·2015·Trends in Immunology
DOI 10.1016/j.it.2015.04.007

Cited by (278)

Items 101–200 of 278

  1. Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases
    Sheena E.B. Tyler, Luke D.K. Tyler · 2023 · IBRO Neuroscience Reports
  2. Selected health and lifestyle factors, cytosine‐adenine‐guanine status, and phenoconversion in Huntington's disease
    Caroline M. Tanner, Karen S. Marder, Shirley W. Eberly, Kevin Biglan, David Oakes, Ira Shoulson, on behalf of the Huntington Study Group Prospective Huntington At‐Risk Observational Study Investigators · 2018 · Movement Disorders
  3. Methylphenidate Attenuates the Cognitive and Mood Alterations Observed inMbnl2Knockout Mice and Reduces Microglia Overexpression
    Carla Ramon‐Duaso, Thomas Gener, Marta Consegal, Cristina Fernández-Avilés, Juan Gallego, Laura Castarlenas, Maurice S. Swanson, Rafael de la Torre, Rafael J. Maldonado, Maria Victoria Puig et al. · 2018 · Cerebral Cortex
  4. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Dahyun Yu, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Acta Neuropathologica Communications
  5. Targeting the Cholinergic System to Develop a Novel Therapy for Huntington’s Disease
    Gary X. D’Souza, Henry John Waldvogel · 2016 · Journal of Huntington s Disease
  6. Mitochondrial Bioenergetics in Brain Following Ozone Exposure in Rats Maintained on Coconut, Fish and Olive Oil-Rich Diets
    Matthew Christopher Valdez, Danielle L. Freeborn, Joseph M. Valdez, Andrew F.M. Johnstone, Samantha J. Snow, Alan H. Tennant, Urmila P. Kodavanti, Prasada Rao S. Kodavanti · 2019 · International Journal of Molecular Sciences
  7. Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy
    Peter de Haan, Hans Christiaan Klein, Bert A. ‘t Hart · 2017 · Frontiers in Psychiatry
  8. Human iPSC‐derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington's disease mouse model
    Hyun Jung Park, Juhyun Jeon, Jiwoo Choi, Ji Yeon Kim, Hyun Sook Kim, Ji Young Huh, Steven A. Goldman, Jihwan Song · 2021 · Cell Proliferation
  9. Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands
    Ferenc Bogár, Lívia Fülöp, Botond Penke · 2022 · Biomolecules
  10. AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington’s disease mouse model
    Sarah B. Thomson, Anouk Stam, Cynthia C. Brouwers, Valentina Fodale, Alberto Bresciani, Michael Vermeulen, Sara Mostafavi, Terri L. Petkau, Austin Hill, Andrew C. Yung et al. · 2022 · Brain
  11. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons
    Andrea Ruiz-Calvo, Raquel Bajo‐Grañeras, Irene B. Maroto, Debora Zian, Gernot F. Grabner, Elena García-Taboada, Eva Resel, Rudolf Zechner, Robert Zimmermann, Silvia Ortega‐Gutiérrez et al. · 2019 · Neuropharmacology
  12. The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
    Alba Di Pardo, Elena Ciaglia, Monica Cattaneo, Anna E. Maciag, Francesco Montella, Valentina Lopardo, Anna Ferrario, Francesco Villa, Michele Madonna, Enrico Amico et al. · 2020 · Cell Death and Disease
  13. New Nrf2-Inducer Compound ITH12674 Slows the Progression of Retinitis Pigmentosa in the Mouse Model rd10
    Laura Campello, Oksana Kutsyr, Agustina Noailles, Patrycja Michalska, Laura Fernández‐Sánchez, Natalia Martínez‐Gil, Isabel Ortuño‐Lizarán, Xavier Sánchez‐Sáez, Emilio de Juan, Pedro Lax et al. · 2018 · Cellular Physiology and Biochemistry
  14. GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington’s Disease-Related Phenotypes
    Congcong Wang, Yufang Zhang, Shimeng Guo, Quan Zhao, Yanping Zeng, Zhicheng Xie, Xin Xie, Boxun Lu, Youhong Hu · 2020 · Journal of Medicinal Chemistry
  15. A meta-analysis of transcriptomic profiles of Huntington’s disease patients
    Manuel Seefelder, Stefan Kochanek · 2021 · PLoS ONE
  16. Enhanced BDNF and TrkB Activation Enhance GABA Neurotransmission in Cerebellum in Hyperammonemia
    Yaiza M. Arenas, Mar Martinez‐García, Marta Llansola, Vicente Felipo · 2022 · International Journal of Molecular Sciences
  17. Glial Cells as Emerging Therapeutic Targets in Neurodegenerative Diseases: Mechanistic Insights and Translational Perspectives
    Thirupathirao Vishnumukkala, Che Mohd Nasril Che Mohd Nassir, Zaw Myo Hein, Prarthana Kalerammana Gopalakrishna, Barani Karikalan, Aisyah Alkatiri, Saravanan Jagadeesan, Venkatesh R Naik, Warren Thomas, Mohamad Aris Mohd Moklas et al. · 2025 · Cells
  18. cGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders
    Fengjuan Li, Ningqun Wang, Yangmin Zheng, Yumin Luo, Yongbo Zhang · 2021 · Aging and Disease
  19. Sirtuins as Modifiers of Huntington's Disease (HD) Pathology
    Sin Hui Neo, Bor Luen Tang · 2017 · Progress in molecular biology and translational science
  20. Modelling the Human Blood–Brain Barrier in Huntington Disease
    Domenico Vignone, Odalys Gonzalez Paz, Ivan Fini, Antonella Cellucci, Giulio Auciello, Maria Rosaria Battista, Isabelle Gloaguen, Silvia Fortuni, Cristina Cariulo, Vinod K. Khetarpal et al. · 2022 · International Journal of Molecular Sciences
  21. Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions
    Brittany N. Szafran, Jung Hwa Lee, Abdolsamad Borazjani, Peter E. Morrison, Grace A. Zimmerman, Kelly L. Andrzejewski, Matthew K. Ross, Barbara L.F. Kaplan · 2018 · Molecules
  22. Convergent mechanisms of microglia‐mediated synaptic dysfunction contribute to diverse neuropathological conditions
    Nicole Scott‐Hewitt, Youtong Huang, Beth Stevens · 2023 · Annals of the New York Academy of Sciences
  23. Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases
    Ruokun Wei, Peiqi Wei, Haiyan Yuan, Xiang Yi, Michael Aschner, Yue‐Ming Jiang, Shaojun Li · 2024 · Biological Trace Element Research
  24. Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate
    Debashis Dutta, Moumita Majumder, Ramesh Kumar Paidi, Kalipada Pahan · 2021 · Neurobiology of Disease
  25. In Situ Detection of Neuroinflammation Using Multicellular 3D Neurovascular‐Unit‐on‐a‐Chip
    Choi, Jin‐Ha, Choi, Hye Kyu, Lee, Ki‐Bum · 2023 · Advanced Functional Materials
  26. Emerging Pro-neurogenic Therapeutic Strategies for Neurodegenerative Diseases: A Review of Pre-clinical and Clinical Research
    Mariana Vassal, Filipa Martins, Bruno Monteiro, Simone Tambaro, Ricardo Martínez‐Murillo, Sandra Rebelo · 2024 · Molecular Neurobiology
  27. MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
    Francesca Garello, Amerigo Pagoto, Francesca Arena, Annalisa Buffo, Francesco Blasi, Diego Alberti, Enzo Terreno · 2017 · Nanomedicine Nanotechnology Biology and Medicine
  28. Ellagic acid rescues motor and cognitive deficits in the R6/2 mouse model of Huntington's disease by lowering mutant huntingtin protein
    Xun Sun, Jie Zhu, Xiaoying Sun, Mei Ji, Xiaolin Yu, Rui‐tian Liu · 2020 · Food & Function
  29. A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease
    Md. Rezaul Islam, Maruf Hossain Jony, Gazi Kaifeara Thufa, Shopnil Akash, Puja Sutro Dhar, Md. Mominur Rahman, Tahmina Afroz, Muniruddin Ahmed, Hassan A. Hemeg, Abdur Rauf et al. · 2023 · Molecular Neurobiology
  30. Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis
    Alireza Soltani Khaboushan, Aysan Moeinafshar, Mohammad Hamed Ersi, Antônio Lúcio Teixeira, Masoumeh Majidi Zolbin, A.M. Kajbafzadeh · 2023 · Journal of Neuroimmunology
  31. Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington’s disease patients
    Marjolein Bulk, Ingrid M. Hegeman-Kleinn, Boyd Kenkhuis, Ernst Suidgeest, Willeke van Roon‐Mom, Jan Lewerenz, Sjoerd G. van Duinen, Itamar Ronen, Louise van der Weerd · 2020 · NeuroImage Clinical
  32. Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets
    Xin Guo, Hui Na Liu, Yu‐Jing Song, Jian‐Hua Wang, Danfeng Liu, Zhi‐Wei Zheng, Jia‐Jun Li, Boya Li, An Song, Wei He et al. · 2026 · MedComm
  33. Mitochondrial DNA: a molecular switch driving sterile neuroinflammation
    Abhishek Jauhari, Tanisha Singh, Diane L. Carlisle, Robert Max Friedlander · 2026 · Translational Neurodegeneration
  34. Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine
    Qian Cao, Randall Tyler Mertens, Kisha Nandini Sivanathan, Xuechun Cai, Peng Xiao · 2022 · Journal of Leukocyte Biology
  35. Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6/1 mouse model with prospects for early diagnosis and monitoring of the disease
    Magdalena Podlacha, Karolina Pierzynowska, Lidia Gaffke, Grażyna Jerzemowska, Ewa Piotrowska, Grzegorz Węgrzyn · 2022 · Brain Behavior & Immunity - Health
  36. The impact of phyto- and endo-cannabinoids on central nervous system diseases：A review
    Shanshan Zhang, Niu-Niu Zhang, Tiantian Guo, Lee‐Yan Sheen, Chi‐Tang Ho, Naisheng Bai · 2022 · Journal of Traditional and Complementary Medicine
  37. Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington’s Disease
    Yousef Tizabi, Samia Bennani, Nacer El Kouhen, Bruk Getachew, Michael Aschner · 2024 · Cells
  38. Inflammatory changes in peripheral organs in the BACHD murine model of Huntington's disease
    Priscila Aparecida Costa Valadão, Bruna da Silva Oliveira, Julliane Vasconcelos Joviano‐Santos, Érica Leandro Marciano Vieira, Natália Pessoa Rocha, Antônio Lúcio Teixeira, Cristina Guatimosim, Aline Silva de Miranda · 2019 · Life Sciences
  39. Neuroinflammation as a therapeutic target in neurodegenerative diseases
    Richard Gordon, Trent M. Woodruff · 2017 · Elsevier eBooks
  40. Hypoxia/Ischemia-Induced Rod Microglia Phenotype in CA1 Hippocampal Slices
    Daniele Lana, Elisabetta Gerace, Giada Magni, Francesca Cialdai, Monica Monici, Guido Mannaioni, Maria Grazia Giovannini · 2022 · International Journal of Molecular Sciences
  41. A small molecule p75<sup>NTR</sup>ligand normalizes signalling and reduces Huntington’s disease phenotypes in R6/2 and BACHD mice
    Simmons, Danielle A., Belichenko, Nadia P., Ford, Ellen C., Semaan, Sarah, Monbureau, Marie, Aiyaswamy, Sruti, Holman, Cameron M., Condon, Christina, Shamloo, Mehrdad, Massa, Stephen M. et al. · 2016 · Human Molecular Genetics
  42. Bioinformatic analysis of microRNA expression in Huntington's disease
    Xiaoyu Dong, Shuyan Cong · 2018 · Molecular Medicine Reports
  43. Inflammasome activation and assembly in Huntington’s disease
    Tiago de Oliveira Furlam, Isadora Gonçalves Roque, Ewelin Wasner Machado da Silva, Pedro Parenti Vianna, Priscila Aparecida Costa Valadão, Cristina Guatimosim, Antônio Lúcio Teixeira, Aline Silva de Miranda · 2022 · Molecular Immunology
  44. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington’s disease
    Nadine A van de Zande, Marjolein Bulk, Chloé Najac, Louise van der Weerd, Jeroen de Bresser, Jan Lewerenz, Itamar Ronen, Susanne Tamara de Bot · 2023 · NeuroImage Clinical
  45. Could metformin be therapeutically useful in Huntington’s disease?
    Bor Luen Tang · 2019 · Reviews in the Neurosciences
  46. Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington’s disease
    Alexander J. Lowe, Filipe Brogueira Rodrigues, Marzena Arridge, Enrico De Vita, Eileanoir B. Johnson, Rachael I. Scahill, Lauren M. Byrne, Rosanna Tortelli, Amanda Heslegrave, Henrik Zetterberg et al. · 2022 · Brain Communications
  47. Regenerative medicine in Huntington’s disease: Strengths and weaknesses of preclinical studies
    Anna Maria Tartaglione, Patrizia Popoli, Gemma Calamandrei · 2017 · Neuroscience & Biobehavioral Reviews
  48. Neuroinflammation in Huntington's disease: Causes, consequences, and treatment strategies
    Alina Blusch, Maria Björkqvist · 2025 · Journal of Huntington s Disease
  49. Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
    Anna D. Grabowska, Mateusz Wątroba, Joanna Witkowska, Agnieszka Mikulska, Nuno Sepúlveda, Dariusz Szukiewicz · 2023 · International Journal of Molecular Sciences
  50. Focused Ultrasound-Mediated Disruption of the Blood–Brain Barrier for AAV9 Delivery in a Mouse Model of Huntington’s Disease
    Bernie Simone Owusu-Yaw, Yongzhi Zhang, Lilyan Garrett, Alvin Yao, Kai Shing, Ana Rita Batista, Miguel Sena‐Esteves, Jaymin Upadhyay, Kimberly B. Kegel-Gleason, Nick Todd · 2024 · Pharmaceutics
  51. Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery
    Ilaria Ceccarelli, Pasquale Fiengo, Rosaria Remelli, Vincenzo Miragliotta, Lara Rossini, Irene Biotti, Alessandra Cappelli, Lara Petricca, Salvatore La Rosa, Andrea Caricasole et al. · 2015 · Neurobiology of Disease
  52. Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases
    Cinzia Volonté, Guoku Hu, Christopher A. Shaw, Viegas Junior Claudio, Joyce Alves dos Santos, Sandra Henriques Vaz, Ana Morais Sebastião, Vladimír J. Balcar, P. David Mozley, Federico Verde et al. · 2026 · Exploration of Neuroprotective Therapy
  53. Nonhuman Primate Models of Huntington’s Disease and Their Application in Translational Research
    Romina Aron Badin · 2018 · Methods in molecular biology
  54. Quantitative susceptibility mapping in the thalamus and basal ganglia of systemic lupus erythematosus patients with neuropsychiatric complaints
    Marjolein Bulk, Thijs W. van Harten, Boyd Kenkhuis, Francesca Inglese, Ingrid M. Hegeman, Sjoerd G. van Duinen, Ece Ercan, César Magro Checa, Jelle J. Goeman, Christian Mawrin et al. · 2021 · NeuroImage Clinical
  55. Phospholipid Profiles Are Selectively Altered in the Putamen and White Frontal Cortex of Huntington’s Disease
    Gabrielle R. Phillips, Sarah E. Hancock, Andrew M. Jenner, Catriona McLean, Kelly Anne Newell, Todd W. Mitchell · 2022 · Nutrients
  56. Advances in Cellular and Cell-Free Therapy Medicinal Products for Huntington Disease Treatment
    Irina Kerkis, Rodrigo Pinheiro Araldi, Cristiane Valverde Wenceslau, Thais Biude Mendes · 2022 · IntechOpen eBooks
  57. The characteristic and prognostic role of blood inflammatory markers in patients with Huntington’s disease from China
    Jean Xia, Yangfan Cheng, Sirui Zhang, Yuanzheng Ma, Jia-Jia Fu, Tianmi Yang, Lingyu Zhang, Jean‐Marc Burgunder, Huifang Shang · 2024 · Frontiers in Neurology
  58. Microglial Dyshomeostasis: A Common Substrate in Neurodevelopmental and Neurodegenerative Diseases
    Vada Andree Furlan, Daria MacAuslan, Khiem Ha, Nitish Patel, Shawn Adam, Beylem Zanagar, Sharmila Venugopal · 2024 · Neuroglia
  59. RTP801/REDD1 Is Involved in Neuroinflammation and Modulates Cognitive Dysfunction in Huntington’s Disease
    Leticia Pérez‐Sisqués, Júlia Solana‐Balaguer, Genís Campoy‐Campos, Núria Martín‐Flores, Anna Sancho‐Balsells, Marcel Vives-Isern, Ferran Soler-Palazón, Marta García-Forn, Mercè Masana, Jordi Alberch et al. · 2021 · Biomolecules
  60. An integrative neuropharmacological review of Huntington’s disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical limitations
    Mahmoud Ahmed Senousy, Aya H. Eid, Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, Heba R. Ghaiad, Riham A. El‐Shiekh, Sadek Ahmed, Hazim O. Khalifa · 2026 · Frontiers in Pharmacology
  61. Nanotechnology in gene delivery for neural regenerative medicine
    Mona Shahlaei, Shaahin Mohammadzadeh Asl, Maryam Saeidifar · 2020 · Elsevier eBooks
  62. Associations of inflammatory cytokines and cortisol with nonmotor features of Huntington's disease
    Hiba Bilal, Stuart J. McDonald, Julie C. Stout, Ian H. Harding · 2024 · Annals of Clinical and Translational Neurology
  63. Epochal neuroinflammatory role of high mobility group box 1 in central nervous system diseases
    Seidu A. Richard, Wu Min, Zhaoliang Su, Huaxi Xu · 2017 · AIMS molecular science
  64. Neuroglial patterns are shared by cerebella from prion and prion-like disorder affected patients
    Moisès Garcés, M. Isabel Guijarro, Antonia Vargas, Juan José Badiola, Marta Monzón · 2019 · Mechanisms of Ageing and Development
  65. Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury
    Mou Gao, Qin Dong, Wenjia Wang, Zhijun Yang, Lili Guo, Yingzhou Lu, Boyun Ding, Lihua Chen, Jianning Zhang, Ruxiang Xu · 2021 · Stem Cell Research & Therapy
  66. The Renin-Angiotensin System in Huntington’s Disease: Villain or Hero?
    Thatiane C. G. Machado, Cristina Guatimosim, Lucas Miranda Kangussu · 2020 · Protein and Peptide Letters
  67. Bridging the Gap: The Neuro-immune Axis as a Key Player in Neurodegenerative Disorders
    Tingting Liu, Haojie Wu, Jianshe Wei · 2025 · Neuroscience Bulletin
  68. Key Features in the Design and Function of Nanocarriers for Intranasal Administration of Gene Therapy in Huntington Disease
    Oksana Fihurka, Stephen D. Aradi, Vasyl Sava, Juan Sanchez‐Ramos · 2023 · Journal of Nanotechnology and Nanomaterials
  69. A Novel Huntington's Disease Mouse Model to Assess the Role of Neuroinflammation on Disease Progression and to Develop Human Cell Therapies
    Heather Dahlenburg, David L. Cameron, Sheng Yang, Angelica M. Bachman, Kari Pollock, Whitney Cary, Missy T. Pham, Kyle J. Hendrix, Jeannine Logan White, Haley Nelson et al. · 2021 · Stem Cells Translational Medicine
  70. Microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin
    Alexander P. Young, Eileen M. Denovan‐Wright · 2024 · Pharmacological Research
  71. Coniferaldehyde reverses 3-nitropropionic acid-induced Huntington’s disease pathologies via PKM2 restoration and JAK2/STAT3 inhibition
    Ayooluwa Gabriel Ibiayo, Peeraporn Varinthra, Mukundan Nagarajan, Ingrid Y. Liu · 2025 · Molecular Medicine
  72. cGAS–STING: From immunology and oncology view
    Xiangxiang Liu, Chengshi Ding, Jun Lü, Na Zhang · 2025 · Chinese Medical Journal
  73. Gasdermins in neurodegeneration: emerging mechanisms and therapeutic targets
    Sizhuo Chen, Jing Zhang, Xin Chen, Zhongmeng Lai, Zhenhuan Zhao, Shao-Bin Wang · 2025 · Cell Death and Disease
  74. Endocytosis of GABA receptor: Signaling in nervous system
    Preeti Sharma, B. Sharan Sharma, Hardik Raval, Vijai Singh · 2022 · Progress in molecular biology and translational science
  75. Brain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions
    Johannes Burtscher, Barbara Strasser, Giuseppe Pepe, Martin Burtscher, Martin Kopp, Alba Di Pardo, Vittorio Maglione, Andy V. Khamoui · 2024 · International Journal of Molecular Sciences
  76. Inflammation and the Brain Disorders: A Review
    Rahimeh Bargi, Hossein Salmani, Fereshteh Asgharzadeh Yazdi, Mahmoud Hosseini · 2017 · The Neuroscience Journal of Shefaye Khatam
  77. Metabolomic Investigation of Synergistic Mechanism for Fangfeng Extract Preventing LPS Induced Neuroinflammation in BV-2 Microglia Cells
    Xinliang Zhu, Xueqi Wang, Shunbin Zhang, Xu Li, Zhengdou Li, Xia Chen, Xiaoxiao Liu, Huixia Li, Ji Zhang · 2021 · Applied Sciences
  78. Two cases of Huntington’s disease unmasked by the COVID-19 pandemic
    Giovanni Palermo, Alessio Di Fonzo, Alessio Francesconi, Elisa Unti, Roberto Ceravolo · 2022 · Neurological Sciences
  79. Neuroinflammation as a therapeutic target in Huntington’s disease
    Andrea Kwakowsky, Thulani Hansika Palpagama · 2024 · Neural Regeneration Research
  80. Electrophysiological insights into Alzheimer's disease: A review of human and animal studies
    Kirsten Calvin, Adam M. McNeela, Amanda M. Leisgang Osse, Guncha Bhasin, Matthew Ridenour, Jefferson W. Kinney, J.M. Hyman · 2024 · Neuroscience & Biobehavioral Reviews
  81. Huntington’s disease
    Sergey A. Klyushnikov · 2020 · L O Badalyan Neurological Journal
  82. Pathophysiological Mechanisms of Huntington’s Disease
    Zuleide Maria Ignácio, João Quevedo, Gislaine Z. Réus · 2018 · Springer eBooks
  83. Volume-of-interest-based supervised cluster analysis for pseudo-reference region selection in [18F]DPA-714 PET imaging of the rat brain
    Igor Fagner Vieira, Dieter Ory, Cindy Casteels, Fernando Roberto de Andrade Lima, Koen Van Laere, Guy M Bormans, Michel J. B. Koole · 2018 · EJNMMI Research
  84. Pyruvate blocks blood-brain barrier disruption, lymphocyte infiltration and immune response in excitotoxic brain injury.
    Jae Kyu Ryu, James G. McLarnon · 2016 · Europe PMC (PubMed Central)
  85. Detection of antibodies against the huntingtin protein in human plasma
    Hélèna L. Denis, Melanie Alpaugh, Claudia Alvarez, Alexis Fenyi, Roger A. Barker, Sylvain Chouinard, C.H. Arrowsmith, Ronald Melki, Richard Labib, Rachel Harding et al. · 2023 · Cellular and Molecular Life Sciences
  86. Neuroprotective effects of lithium in neuropsychiatric disorders
    Galila Agam, Joseph Levine · 2019 · Elsevier eBooks
  87. Anti-inflammatory role of GM1 and modulatory effects of gangliosides on microglia functions
    Danny Galleguillos, Qian Wang, Noam Steinberg, Gaurav Shrivastava, Kamaldeep Dhami, Karin Rubinstein, Fabrizio Giuliani, Matthew A. Churchward, Christopher Power, Kathryn G. Todd et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Neuroinflammatory control of metabolism in huntington’s disease: central role of P2 × 7 receptor mediated redox lipid/epigenetic crosstalk
    Vandana Bhatia, Gayatri Bisht, Tanika Thakur, Harshita Thakur, Mahendra Singh Ashawat · 2026 · Inflammopharmacology
  89. Peripheral and central elevation of IL-8 in patients with Huntington’s disease
    Jenny N. Fung, John D. Lee, Robert J. Adam, John D. O’Sullivan, Trent M. Woodruff · 2025 · Molecular Immunology
  90. Microglia Mediate Early Corticostriatal Synapse Loss and Cognitive Dysfunction in Huntington’s Disease Through Complement-Dependent Mechanisms
    Daniel K. Wilton, Kevin J. Mastro, Molly D. Heller, Frederick W. Gergits, Carly Rose Willing, Arnaud Frouin, Anthony Daggett, Xiaofeng Gu, Anika Y. Kim, Richard L. M. Faull et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington’s disease
    Louis-Habib Parsai, Farah Chali, Enejda Subashi, Caroline Zeitouny, Emilie Rey, Aurélie Berniard, William Bitton, Laureline Urli, Lisa Rousselot, Nadège Sarrazin et al. · 2025 · Acta Neuropathologica Communications
  92. Complement in Human Brain Health: Potential of Dietary Food in Relation to Neurodegenerative Diseases
    Yihang Xing, Dingwen Zhang, Li Fang, Ji Wang, Chunlei Liu, Dan Wu, Xiaoting Liu, Xiyan Wang, Weihong Min · 2023 · Foods
  93. Microglial immune memory in Parkinson’s and Huntington’s diseases: epigenetics, triggers, and therapies
    Reema Chowdhury, Anna Hendlinger, Olaf Rieß, Julia Maria Schulze-Hentrich · 2025 · Epigenomics
  94. A Two-Track Model of Huntington’s Disease Pathology: Striatal Atrophy Mediates Maladaptive Immune Dysregulation
    H. Jeremy Bockholt, Jordan D. Clemsen, Bradley T. Baker, Vince D. Calhoun, Jane S. Paulsen · 2026 · International Journal of Molecular Sciences
  95. The Endocannabinoid System in Local and Systemic Inflammation
    Melanie E. M. Kelly, Christine Lehmann, Juan Zhou · 2017 · Colloquium Series on Integrated Systems Physiology From Molecule to Function
  96. The Huntington’s disease drug pipeline: a review of small molecules and their therapeutic targets
    Sameera Khan, Nargis Bano, Vladimir Nikolaevich Uversky, Shakir Ahamad, Shahnawaz Ali Bhat · 2024 · Progress in molecular biology and translational science
  97. Adenosine Receptors and Neuroinflammation
    Antonella Ferrante, Roberta De Simone, Maria Antonietta Ajmone‐Cat, Luisa Minghetti, Patrizia Popoli · 2018 · Springer eBooks
  98. The multitude of therapeutic targets in neurodegenerative proteinopathies
    Ronald Melki · 2017 · Elsevier eBooks
  99. Impaired Replenishment of Cortico-Striatal Synaptic Glutamate in Huntington’s Disease Mouse Model
    Caodu Buren, Gaqi Tu, Lynn A. Raymond · 2020 · Journal of Huntington s Disease
  100. Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases
    A. A. Farooqui · 2021 · Elsevier eBooks